Schuler Trust buys Aspira (AWHL) stock plus $0.75 warrants in June 2026 deal

Rhea-AI Filing Summary

Jack W. Schuler and the Jack W. Schuler Living Trust updated their ownership disclosure in Aspira Women's Health Inc. following a new private purchase. On June 5, 2026, the Trust bought 222,222 shares of common stock and a warrant to purchase 300,000 additional shares under a June 2026 Securities Purchase Agreement.

After this transaction, Mr. Schuler reports beneficial ownership of 4,052,587 shares, or 8.7% of Aspira’s common stock, with most shares held through the Trust. The Trust alone reports 4,046,051 shares, or 8.6% of the company, based on 46,800,411 shares outstanding after including recent issuances.

Key Figures

Schuler beneficial ownership: 4,052,587 shares (8.7%) Trust beneficial ownership: 4,046,051 shares (8.6%) Shares outstanding baseline: 46,800,411 shares +3 more

6 metrics

Schuler beneficial ownership 4,052,587 shares (8.7%) Common stock beneficially owned after June 5, 2026 transaction

Trust beneficial ownership 4,046,051 shares (8.6%) Jack W. Schuler Living Trust stake in Aspira common stock

Shares outstanding baseline 46,800,411 shares 43,500,411 shares as of May 12, 2026 plus 3,300,000 June 2026 issuance

New common shares purchased 222,222 shares Common stock bought by the Trust on June 5, 2026

June 2026 warrant size 300,000 shares Shares underlying warrant purchased by the Trust

Warrant exercise price $0.75 per share Exercise price of June 2026 warrant, exercisable for three years

Key Terms

Securities Purchase Agreement, warrant, beneficially owned, dispositive power, +1 more

5 terms

Securities Purchase Agreement financial

"the Trust entered into a Securities Purchase Agreement, dated as of such date, among the Issuer, the Trust, and the other purchasers"

A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.

warrant financial

"a warrant to purchase 300,000 shares of Common Stock (the " June 2026 Warrant")"

A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.

beneficially owned financial

"Aggregate amount beneficially owned by each reporting person 4,052,587.00"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

dispositive power financial

"Sole Dispositive Power 6,536.00 10 | Shared Dispositive Power 4,046,051.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Schedule 13D regulatory

"If the filing person has previously filed a statement on Schedule 13G to report the acquisition"

A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/11/2026 - 04:06 PM Accepted by SEC EDGAR 06/11/2026 - 04:05 PM Learn about SEC filing dates

FAQ

What stake does Jack W. Schuler report in Aspira Women's Health (AWHL)?

Jack W. Schuler reports beneficial ownership of 4,052,587 Aspira shares, representing 8.7% of the common stock. Most of this stake is held through the Jack W. Schuler Living Trust, reflecting a significant but non‑controlling shareholder position in the company.

How many Aspira shares does the Jack W. Schuler Living Trust hold?

The Jack W. Schuler Living Trust reports beneficial ownership of 4,046,051 Aspira common shares, equal to 8.6% of the company. These shares are reported with shared voting and dispositive power, with Mr. Schuler serving as the sole trustee of the Trust.

What new securities did the Schuler Trust acquire from Aspira Women's Health?

On June 5, 2026, the Trust purchased 222,222 Aspira common shares and a warrant to buy 300,000 additional shares. The warrant is exercisable at $0.75 per share for three years from issuance, providing potential future equity exposure if exercised.

What is the exercise price and term of the June 2026 Aspira warrant?

The June 2026 warrant held by the Trust allows purchase of 300,000 Aspira common shares at an exercise price of $0.75 per share. It is exercisable for three years from its June 5, 2026 issuance date, giving a defined window for potential share acquisition.

How many Aspira shares are used to calculate Schuler's ownership percentage?

The reported ownership percentages are based on 46,800,411 Aspira shares outstanding. This figure combines 43,500,411 shares outstanding as of May 12, 2026, plus 3,300,000 new shares sold under the June 2026 Purchase Agreement referenced in the amended filing.

Did Jack W. Schuler or the Trust trade Aspira shares in the prior 60 days?

The filing states that neither Jack W. Schuler nor the Trust effected transactions in Aspira shares during the 60 days before the amendment date. The notable activity disclosed is the June 5, 2026 purchase under the June 2026 Securities Purchase Agreement.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 19)

Aspira Women's Health Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

04537Y208

(CUSIP Number)

Jack W. Schuler
PO Box 531,
Lake Bluff, IL, 60044
(520) 906-2991

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

06/05/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 04537Y208

1

Name of reporting person

SCHULER JACK W

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 6,536.00
8	Shared Voting Power 4,046,051.00
9	Sole Dispositive Power 6,536.00
10	Shared Dispositive Power 4,046,051.00

11

Aggregate amount beneficially owned by each reporting person

4,052,587.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

8.7 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 04537Y208

1

Name of reporting person

Jack W. Schuler Living Trust

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

ILLINOIS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 4,046,051.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 4,046,051.00

11

Aggregate amount beneficially owned by each reporting person

4,046,051.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

8.6 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, $0.001 par value
(b)	Name of Issuer: Aspira Women's Health Inc.
(c)	Address of Issuer's Principal Executive Offices: 12117 BEE CAVES ROAD BUILDING THREE, Suite 100, Austin, TEXAS , 78738.
Item 4.	Purpose of Transaction
	This Amendment No. 19 to Schedule 13D (this "Amendment") hereby amends and supplements Item 4 by adding the following thereto: "The disclosure set forth in Items 5 and 6 below is hereby incorporated by reference in this Item 4. On June 5, 2026, the Trust purchased from the Issuer the Common Stock and June 2026 Warrants pursuant to the June 2026 Purchase Agreement (in each case as defined and further described in Item 6 below)."
Item 5.	Interest in Securities of the Issuer
(a)	This Amendment hereby amends and restates Item 5(a) in its entirety as follows: "The information set forth in Rows 7 through 13 of the cover page hereto for each of Mr. Schuler and the Trust is incorporated herein by reference. The percentage amount set forth in Row 13 for all cover pages filed herewith is calculated based upon the 43,500,411 Shares outstanding as of May 12, 2026, as reported by the Issuer in its Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on May 15, 2026 plus the 3,300,000 shares of Common Stock sold pursuant to the June 2026 Purchase Agreement for a total of 46,800,411 Shares outstanding."
(b)	This Amendment hereby amends and restates Item 5(b) in its entirety as follows: "The information set forth in Rows 7 through 13 of the cover page hereto for each of Mr. Schuler and the Trust is incorporated herein by reference."
(c)	This Amendment hereby amends and restates Item 5(c) in its entirety as follows: "Neither Mr. Schuler nor the Trust has effected any transactions in the Shares during the 60 days prior to the date hereof."
(d)	This Amendment hereby amends and restates Item 5(d) in its entirety as follows: "The Trust has the power to direct the receipt of dividends relating to, or the disposition of the proceeds of the sale of, the Shares held by it and the Shares that it has the right to acquire upon the exercise of 2022 Warrants, January 2024 Warrants, February 2025 Warrants, September 2025 Warrants and June 2026 Warrants. Mr. Schuler is the sole trustee of the Trust."
(e)	This Amendment hereby amends and restates Item 5(e) in its entirety as follows: "Not applicable."
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	This Amendment hereby amends and supplements Item 6 by adding the following thereto: "The disclosure set forth in Items 4 and 5 above is hereby incorporated by reference in this Item 6. June 2026 Purchase Agreement and Common Stock and June 2026 Warrant On June 5, 2026, the Trust entered into a Securities Purchase Agreement, dated as of such date, among the Issuer, the Trust, and the other purchasers party thereto (the "June 2026 Purchase Agreement"), pursuant to which the Trust purchased from the Issuer the Common Stock and June 2026 Warrant (as defined below). The June 2026 Purchase Agreement contained customary terms and conditions. The foregoing description of the June 2026 Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the form thereof attached hereto as Exhibit 16, which exhibit is hereby incorporated herein by reference. On June 5, 2026, pursuant to the June 2026 Purchase Agreement, the Trust purchased from the Issuer 222,222 shares of Common Stock (the "Common Stock") and a warrant to purchase 300,000 shares of Common Stock (the " June 2026 Warrant"). The June 2026 Warrant is exercisable at $0.75 per share for three (3) years from the date of issuance. The foregoing description of the June 2026 Warrant does not purport to be complete and is qualified in its entirety by reference to the form thereof attached hereto as Exhibit 17, which exhibit is hereby incorporated herein by reference."
Item 7.	Material to be Filed as Exhibits.
	This Amendment hereby amends and supplements Item 7 by adding the following thereto: "There is filed herewith as Exhibit 16 the form of June 2026 Purchase Agreement. There is filed herewith as Exhibit 17 the form of June 2026 Warrant."

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SCHULER JACK W

Signature:	/s/ Jack W Schuler
Name/Title:	Jack W. Schuler
Date:	06/11/2026

Jack W. Schuler Living Trust

Signature:	/s/ Jack W Schuler
Name/Title:	Jack W Schuler, Sole Trustee
Date:	06/11/2026